Department of Plastic and Reconstructive Surgery, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
Department of Surgery, Maastricht University Medical Center, P. Debyelaan 25, 6229HX, Maastricht, The Netherlands.
Hernia. 2021 Apr;25(2):321-329. doi: 10.1007/s10029-020-02167-w. Epub 2020 Mar 26.
No previous study reported the use of a fasciocutaneous anterolateral thigh (ALT) flap combined with a biological mesh for abdominal wall reconstruction (AWR) after enterocutaneous fistula (ECF) in a single-staged procedure and the use of Indocyanine Green Angiography (ICGA) intraoperatively. The purpose of this study was to determine the feasibility and safety of this procedure and to examine the added value of ICGA in minimizing postoperative complications.
A single-institution review of a prospectively maintained database was conducted at Maastricht University Medical Center. To evaluate the feasibility and safety of this procedure, early (≤ 30 days) and late (> 30 days) postoperative complications were assessed. ECF recurrence was considered the primary outcome. To examine the added value of ICGA, complications in the ICGA group and the non-ICGA group were compared descriptively.
Ten consecutive patients, with a mean age of 66.7 years, underwent a single-staged AWR with fasciocutaneous ALT flaps. Mean follow-up was 17.4 months (4.3-28.2). Two early ECF recurrences were observed. Both restored without the need for reoperation. A lower rate of early complications was observed in the ICGA group compared to the non-ICGA group.
The combination of a biological mesh and fasciocutaneous ALT flap is feasible and safe in AWR after ECF repair in a single-staged approach, with an acceptable complication rate in a cohort of complex patients operated in a dedicated center. ECF closure was achieved in all patients. ICGA seems to be of great added value in minimizing postoperative complications during AWR.
之前没有研究报道过在单阶段手术中使用筋膜皮瓣前外侧大腿(ALT)皮瓣结合生物网片进行肠外瘘(ECF)后的腹壁重建(AWR),也没有报道过术中使用吲哚菁绿血管造影(ICGA)。本研究旨在确定该方法的可行性和安全性,并研究 ICGA 在减少术后并发症方面的附加价值。
对马斯特里赫特大学医学中心前瞻性维护的数据库进行了单机构回顾。为了评估该方法的可行性和安全性,评估了早期(≤30 天)和晚期(>30 天)术后并发症。ECF 复发被认为是主要结局。为了研究 ICGA 的附加价值,对 ICGA 组和非 ICGA 组的并发症进行了描述性比较。
连续 10 例患者,平均年龄为 66.7 岁,行筋膜皮瓣前外侧大腿单阶段 AWR。平均随访时间为 17.4 个月(4.3-28.2)。观察到 2 例早期 ECF 复发。均无需再次手术即可恢复。ICGA 组的早期并发症发生率低于非 ICGA 组。
在单阶段手术中,生物网片和筋膜皮瓣前外侧大腿联合应用于 ECF 修复后的 AWR 是可行和安全的,在一个专门中心为复杂患者进行手术的队列中,并发症发生率可接受。所有患者均成功闭合 ECF。ICGA 在最小化 AWR 术后并发症方面似乎具有很大的附加价值。